Immediate Impact
2 from Science/Nature 63 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Works of Lorin A. Ferris being referenced
Increased Hepatotoxicity Associated with Sequential Immune Checkpoint Inhibitor and Crizotinib Therapy in Patients with Non–Small Cell Lung Cancer
2018
Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non–Small-Cell Lung Cancer
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Lorin A. Ferris | 496 | 373 | 243 | 10 | 594 | |
| Minhao Fan | 265 | 304 | 174 | 11 | 526 | |
| Sherry Li | 497 | 400 | 275 | 16 | 663 | |
| Shotaro Iwakiri | 360 | 391 | 233 | 16 | 667 | |
| R Gray | 265 | 434 | 185 | 15 | 721 | |
| Viktor Svekolkin | 262 | 395 | 295 | 11 | 692 | |
| Tahsin M. Khan | 355 | 333 | 268 | 19 | 573 | |
| Hielke J. Meulenbeld | 314 | 280 | 147 | 17 | 569 | |
| José Elias Miziara | 485 | 381 | 246 | 16 | 651 | |
| Bárbara Angulo | 330 | 382 | 372 | 17 | 717 | |
| Monika Jermann | 394 | 216 | 139 | 11 | 638 |
All Works
Loading papers...